Stay informed with the latest litigation news. Explore now
Once Daily Formulation Of Lacosamide - EP2645997B1
EP2645997
- Application Number
- EP11791442A
- Filing Date
- Dec 1, 2011
- Status
- Revoked
- Sep 6, 2024
- Grant Date
- Aug 10, 2022
- External Links
- Slate, Register, Google Patents
- Similar Patents facing opposition
Bibliography
The patent EP2645997B1 was granted to UCB Pharma on Aug 10, 2022 following the initial filing on Dec 1, 2011 under the application number EP11791442A . The current legal status of the patent is Revoked.
Patent Summary
Patent Family New
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.
Date
Description
Get instant alerts for new documents